Esperion Therapeutics Inc (NAS:ESPR)
$ 2.12 0.12 (6%) Market Cap: 415.99 Mil Enterprise Value: 472.28 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 53/100

Esperion Therapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 14, 2020 / 07:45PM GMT
Release Date Price: $38.8 (+2.54%)
Jason Russell;Morgan Stanley;Executive Director

Good afternoon, everyone. My name is Jason Russell with the Morgan Stanley healthcare investment banking team. Thanks for joining us for the Esperion fireside chat. I've got the pleasure to have Tim Mayleben, CEO of Esperion, and we're going to jump into things momentarily.

Before we jump in, I would like to read a brief disclaimer. Please note that this webcast is for Morgan Stanley client and appropriate Morgan Stanley employees only. This webcast is not for members of the press. If you are a member of the press, please disconnect and reach out separately. For important disclaimers, please see the Morgan Stanley Research Disclosures website at www.morganstanley.com/researchdisclosures. If you have any questions, please reach out to your Morgan Stanley sales representative.

With that quite a mouthful, I'd like to jump right in. I think Tim is actually going to kick off. For those of you who may not be quite as familiar with

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot